What are you looking for today?

Urban-Wójciuk, Zuzanna, Graham, Amy, Barker, Karen, Kwok, Colin, Sbirkov, Yordan, Howell, Louise, Campbell, James, Woster, Patrick M, Poon, Evon, Petrie, Kevin and Chesler, Louis (2021) The biguanide polyamine analog verlindamycin promotes differentiation in neuroblastoma via induction of antizyme. Cancer gene therapy. ISSN 1476-5500

Document

Abstract

Abstract

Deregulated polyamine biosynthesis is emerging as a common feature of neuroblastoma and drugs targeting this metabolic pathway such as DFMO are in clinical and preclinical development. The polyamine analog verlindamycin inhibits the polyamine biosynthesis pathway enzymes SMOX and PAOX, as well as the histone demethylase LSD1. Based on our previous research in acute myeloid leukemia (AML), we reasoned verlindamycin may also unblock neuroblastoma differentiation when combined with all-trans-retinoic acid (ATRA). Indeed, co-treatment with verlindamycin and ATRA strongly induced differentiation regardless of MYCN status, but in MYCN-expressing cells, protein levels were strongly diminished. This process was not transcriptionally regulated but was due to increased degradation of MYCN protein, at least in part via ubiquitin-independent, proteasome-dependent destruction. Here we report that verlindamycin effectively induces the expression of functional tumor suppressor-antizyme via ribosomal frameshifting. Consistent with previous results describing the function of antizyme, we found that verlindamycin treatment led to the selective targeting of ornithine decarboxylase (the rate-limiting enzyme for polyamine biosynthesis) as well as key oncoproteins, such as cyclin D and Aurora A kinase. Retinoid-based multimodal differentiation therapy is one of the few interventions that extends relapse-free survival in MYCN-associated high-risk neuroblastoma and these results point toward the potential use of verlindamycin in this regimen. [Abstract copyright: © 2021. The Author(s).]

Item Type: Article
Additional Information: ** From PubMed via Jisc Publications Router ** History: received 30-04-2021; revised 09-08-2021; accepted 27-08-2021.
SWORD Depositor: Publication Router
Depositing User: Kevin Petrie
URI: https://sure.sunderland.ac.uk/id/eprint/14077

Further Details

More Information

Additional Information
** From PubMed via Jisc Publications Router ** History: received 30-04-2021; revised 09-08-2021; accepted 27-08-2021.
SWORD Depositor
Depositing User

Identifiers

Item ID
14077
Identification Number
ISSN
1476-5500

Users with ORCIDS

ORCID for Zuzanna Urban-Wójciuk
ORCID for Amy Graham
ORCID for Patrick M Woster
ORCID for Evon Poon
ORCID for Kevin Petrie

Catalogue record

Date Deposited
04 Nov 2021 11:34
Last Modified
04 Jun 2025 16:16

Contributors

Author
Author
Author
Karen Barker
Author
Colin Kwok
Author
Yordan Sbirkov
Author
Louise Howell
Author
James Campbell
Author
Louis Chesler

University Divisions

Actions (login required)

View Item (Repository Staff Only)

Downloads per month over past year